Emory University researchers identified a 10-protein blood signature that detects amyotrophic lateral sclerosis (ALS) with 98.3% accuracy using Alamar Biosciences' NULISA technology. This multi-protein signature outperforms the current leading biomarker, neurofilament light chain, and can detect ALS even in patients with mild symptoms. The discovery could lead to earlier and more accurate ALS diagnosis, though it remains a research finding and not yet a clinical test. Further studies will explore its potential in larger, diverse patient groups.
The Emory researchers' discovery of a blood protein signature for ALS detection is presented here with Pluang's health sector market data as context. For readers following health stocks, as of Oct 29, 2026 03:21 WIB, 103 of 150 priced US health stocks rose while 46 fell. Among notable movers, AXGN surged 30.75% to USD 48.98 with a buy skew of 63%, contrasting with NUWE which rose 17.26% to USD 6.25 but saw 74% sell orders, and DNA increased 18.28% to USD 13.33 with a more balanced buy-sell split.
SpaceX reported a strong Q3 with revenue up 161% year-over-year to $14.6 billion and a net profit of $4.4 billion, reversing last year's loss. Starlink, its satellite internet service, grew revenue by nearly 70% to $5.2 billion and added 1.6 million ...
SPIE, a leading European multi-technical services provider, has signed an agreement to acquire a 76% stake in SAR ANLAGENBAU GmbH, a major electrical engineering and automation firm based in Austria and Germany. This acquisition will enhance SPIE's p...
SPIE, a European leader in energy and communication services, has agreed to acquire a 76% stake in SAR ANLAGENBAU GmbH, a key electrical engineering and automation firm in Austria and Germany. This acquisition will broaden SPIE's service portfolio in...
The global dermatological therapeutics market is projected to grow from about $43 billion in 2025 to $97 billion by 2034, with a compound annual growth rate of around 10%. This growth is fueled by increasing cases of acne, psoriasis, and other chroni...
Blockchain.com has launched TRX options trading, providing easier access to TRON's native token through its platform. This move expands the TRON ecosystem's reach by simplifying options trading for retail and institutional users worldwide. TRON, know...
